Mahsa Hajivalili - Concepedia

Author

Mahsa Hajivalili

Tabriz University of Medical Sciences ORCID

Also Known As

M Hajivalili, Mahsa Hajivalili, Mahsa hajivalili

Publications

450

Citations

H-Index

Concepts

All Affiliations

Tabriz University of Medical Sciences Shahid Beheshti University of Medical Sciences Tarbiat Modares University Alborz University of Medical Sciences Jahrom University of Medical Sciences

About

Mahsa Hajivalili is an author at Tabriz University of Medical Sciences specializing in medicine, covid-19, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	196
2	Engineering	2	2	52
3	Biomedical Engineering	2	2	52
4	Cell Biology	2	2	68
5	Biomolecular Engineering	1	1	33

Mahsa Hajivalili

Publications

267

Citations

H-Index

Page 1

	Year	Citations
Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression Ata Mahmoodpoor, Maryam Hosseini, Mohammad Sadegh Soltani‐Zangbar, Molecular Immunology Prognostic FactorsCovid-19 ProgressionT-regulatory CellImmunologyPathology	2021	57
The anti-tumor effects of CT-26 derived exosomes enriched by MicroRNA-34a on murine model of colorectal cancer Maryam Hosseini, Kaveh Baghaei, Mahsa Hajivalili, Life Sciences Tumor BiologyOncologyMedicineMurine ModelColorectal Cancer	2021	35
Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line Hajar Shali, Mahdi Shabani, Fatemeh Pourgholi, Artificial Cells Nanomedicine and Biotechnology EngineeringBiomedical EngineeringIgf-1r SirnaNanomedicineRadiation Oncology	2017	33
G2013 modulates TLR4 signaling pathway in IRAK-1 and TARF-6 dependent and miR-146a independent manner. Mahsa Hajivalili, Fatemeh Pourgholi, Jafar Majidi, PubMed	2016	29
Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donation Mohammad Sadegh Soltani‐Zangbar, Leili Aghebati‐Maleki, Mahsa Hajivalili, Gene Reports Point-of-care TestingViral DiagnosticsMedicineReal-time PcrDiagnostic Test	2021	20
SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line. Mehrnush Seifi-Najmi, Mahsa Hajivalili, Reza Safaralizadeh, Cellular and Molecular Biology NanoparticlesNanotherapeuticsEngineeringBiomedical EngineeringTumor Biology	2016	19
SARS-CoV2 infection induce miR-155 expression and skewed Th17/Treg balance by changing SOCS1 level: A clinical study Mohammad Sadegh Soltani‐Zangbar, Mahsa Hajivalili, Danyal Daneshdoust, Cytokine Sars-cov2 InfectionImmunologyMir-155 ExpressionPathologySocs1 Level	2023	18
The Role of M2000 as an Anti-inflammatory Agent in Toll-Like Receptor 2/microRNA-155 Pathway. Fatemeh Pourgholi, Mahsa Hajivalili, Rasoul Razavi, PubMed	2017	17
Prevalence of SARS-CoV-2 Specific Antibodies in Asymptomatic Hemodialysis Patients Jalal Etemadi, Shima Bordbar, Mohammad Sadegh Soltani‐Zangbar, Immunological Investigations	2021	15
Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges Mahsa Hajivalili, Maryam Hosseini, Mostafa Haji-Fatahaliha Life Sciences Viral PersistenceNovel CoronavirusCovid-19 PandemicViral PathogenesisImmunology	2020	14

Page 1